Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $10.89 and traded as high as $11.00. Cipher Pharmaceuticals shares last traded at $11.00, with a volume of 997 shares trading hands.
Cipher Pharmaceuticals Price Performance
The business has a 50-day simple moving average of $10.89 and a two-hundred day simple moving average of $10.79.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.
In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).
Recommended Stories
- Five stocks we like better than Cipher Pharmaceuticals
- CSE: ALEN.U is targeting a fast-growing digital wellness market
- New Copper-Rich “Kraken” Zone Discovered
- Silver paying 20% dividend. Plus 68% share gains
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Your name isn’t on our protected list yet
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
